BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32400945)

  • 1. Clinical course of Immunoglobulin A nephropathy with crescents in a multi-ethnic Southeast Asian cohort.
    Lim CC; Baikunje S; Choo JCJ; Tan PH; Foo M; Woo KT
    Nephrology (Carlton); 2020 Sep; 25(9):708-713. PubMed ID: 32400945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crescentic IgA nephropathy in children.
    Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
    Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
    J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy.
    Alvarado AS; Andeen NK; Brodsky S; Hinton A; Nadasdy T; Alpers CE; Blosser C; Najafian B; Rovin BH
    Nephrol Dial Transplant; 2018 Jul; 33(7):1168-1175. PubMed ID: 28992348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
    Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
    Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C
    Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of IgA nephropathy patients with different proportions of crescents.
    Zhang W; Zhou Q; Hong L; Chen W; Yang S; Yang Q; Chen W; Yu X
    Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
    J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA Nephropathy with Crescents: A Single-Center Experience.
    Ramani N; Whittier WL; Korbet SM
    Am J Nephrol; 2022; 53(11-12):786-793. PubMed ID: 36630925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crescents formations are independently associated with higher mortality in biopsy-confirmed immunoglobulin A nephropathy.
    Chen CH; Wu MJ; Wen MC; Tsai SF
    PLoS One; 2020; 15(7):e0237075. PubMed ID: 32735632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria.
    Pei G; Tan J; Tang Y; Tan L; Zhong Z; Zhou L; Chen C; Qin W
    Medicine (Baltimore); 2020 Jun; 99(24):e20513. PubMed ID: 32541473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J; Xu H; Peng Z; Lin L; Li C; Zhu X; Liu S
    Clin Exp Nephrol; 2020 Jan; 24(1):73-81. PubMed ID: 31605314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Presentation of Immunoglobulin A Nephropathy: Acute Kidney Injury.
    Oruc M; Durak H; Yalin SF; Seyahi N; Altıparmak MR; Trabulus S
    Nephron; 2017; 137(1):8-14. PubMed ID: 28743127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Japanese histologic classification 2013 of immunoglobulin A nephropathy for prediction of long-term prognosis in a Japanese single-center cohort.
    Sato R; Joh K; Komatsuda A; Ohtani H; Okuyama S; Togashi M; Omokawa A; Nara M; Nagata D; Kusano E; Sawada K; Wakui H
    Clin Exp Nephrol; 2015 Jun; 19(3):411-8. PubMed ID: 25002018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implication of crescentic lesions in immunoglobulin A nephropathy.
    Lee MJ; Kim SJ; Oh HJ; Ko KI; Koo HM; Kim CH; Doh FM; Yoo TH; Kang SW; Choi KH; Lim BJ; Jeong HJ; Han SH
    Nephrol Dial Transplant; 2014 Feb; 29(2):356-64. PubMed ID: 24081867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.